Budget Amount *help |
¥45,110,000 (Direct Cost: ¥34,700,000、Indirect Cost: ¥10,410,000)
Fiscal Year 2022: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000)
Fiscal Year 2021: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000)
Fiscal Year 2020: ¥15,470,000 (Direct Cost: ¥11,900,000、Indirect Cost: ¥3,570,000)
|
Outline of Final Research Achievements |
The unique ChILSeq method facilitated single-cell level epigenome data acquisition. An innovative multi-omics analysis integrated ChILSeq with a novel immunostaining method and a spatial transcriptome technique, PIC. This application in tissues allows intra-tissue epigenomic changes analysis. RNA was reverse-transcribed into dsDNA, amplified via in vitro transcription for single-cell RNA detection. Specific antibodies labeled with erasable fluorescence were used to analyze a wide variety of antibodies within the same specimen. The ongoing comprehensive data analysis aims to identify cell populations in skeletal muscle regeneration, with paper submission and patent application in progress.
|